loadpatents
name:-0.015629053115845
name:-0.0058121681213379
name:-0.006850004196167
INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES Patent Filings

INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES

Patent Applications and Registrations

Patent applications and USPTO patent grants for INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES.The latest application filed is for "use of mirna 148 cluster as marker for diagnosing and/or treating cognitive impairment-associated diseases".

Company Profile
6.10.15
  • INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES - Beijing CN
  • INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES - NO. 1 TIANTAN XILI BEIJING, SWITZERLAND CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hydroxamic Acid Derivative, Method For Producing Same And Use Thereof
App 20220033369 - Wang; Yucheng ;   et al.
2022-02-03
USE OF miRNA 148 CLUSTER AS MARKER FOR DIAGNOSING AND/OR TREATING COGNITIVE IMPAIRMENT-ASSOCIATED DISEASES
App 20220033816 - LIU; Rui ;   et al.
2022-02-03
Use of (benzenesulfonamido) benzamide compounds for inhibiting liver fibrosis
Grant 10,933,038 - Tian , et al. March 2, 2
2021-03-02
Use Of Berbamine Dihydrochloride In Preparation Of Ebola Virus Inhibitor
App 20200281916 - CEN; Shan ;   et al.
2020-09-10
Polymyxin Derivative, Preparation Method And Application Thereof
App 20190315806 - CUI; ALONG ;   et al.
2019-10-17
Use Of (benzenesulfonamido)benzamide Compounds For Inhibiting Liver Fibrosis
App 20190274979 - Tian; Hongwei ;   et al.
2019-09-12
Type of antiviral compound
Grant 10,252,987 - Li , et al.
2019-04-09
Use Of (benzenesulfonamido) Benzamide Compounds For Inhibiting Liver Fibrosis
App 20180333376 - Tian; Hongwei ;   et al.
2018-11-22
New Type Of Antiviral Compound
App 20180208549 - Li; Yanping ;   et al.
2018-07-26
Phenanthridine derivatives, preparation methods and uses thereof
Grant 9,682,954 - Hao , et al. June 20, 2
2017-06-20
Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism
Grant 9,616,086 - Hong , et al. April 11, 2
2017-04-11
Cajanine structure analogous compound, preparation method and use
Grant 9,359,298 - Li , et al. June 7, 2
2016-06-07
Use of MicroRNA or Inhibitors Thereof in Regulation of Lipid Metabolism
App 20160089390 - HONG; Bin ;   et al.
2016-03-31
Phenanthridine Derivatives, Preparation Methods and Uses Thereof
App 20160083364 - Hao; Xiaojiang ;   et al.
2016-03-24
Phenyl-oxazolyl Derivatives, Preparation Method Thereof, And Related Application Of The Phenyl-oxazolyl Derivatives As An Impdh Inhibitor
App 20150031686 - Zhong; Zhaojin ;   et al.
2015-01-29
Cajanine Structure Analogous Compound, Preparation Method And Use
App 20140371232 - Li; Zhuorong ;   et al.
2014-12-18
Set of Geldanamycin Derivatives and Their Preparation Methods
App 20100311694 - Li; Zhuorong ;   et al.
2010-12-09
Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae
App 20080044412 - Miao; Qingfang ;   et al.
2008-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed